Stanford Medicine is applying high-tech approaches to reshape medical research, training, diagnostics and treatment — without losing the essential human touch.

Stanford researchers used focused ultrasound to pry molecules of an anesthetic loose from nanoparticles. The drug’s release modified activity in brain regions targeted by the ultrasound beam.

Over 400,000 people have enrolled in a study being conducted by researchers at Stanford and Apple to determine whether a wearable technology can identify irregular heart rhythms suggestive of atrial fibrillation.

A computational tool designed by Stanford scientists makes it easier to identify the source of bloodstream infections and, ideally, rid patients of reservoirs where potentially troublesome microbes reside.

A network of doctors that aims to diagnose mystery diseases has named 31 newly identified conditions and diagnosed more than 100 previously unsolved cases, according to a new study.

Stanford scientists have measured the human “exposome,” or the particulates, chemicals and microbes that individually swaddle us all, in unprecedented detail.

The summer issue of Stanford Medicine highlights research and programs that reflect a shared vision for the future of the School of Medicine, Stanford Health Care and Lucile Packard Children’s Hospital Stanford.

By combining genome-sequence information and health records, Stanford scientists have developed a new algorithm that can predict the risk of abdominal aortic aneurysm, and potentially could be used for any number of diseases.

Changes in circulating tumor DNA levels quickly predict how patients with diffuse large B cell lymphoma are responding to therapy, according to a Stanford-led study. Currently, patients wait months for the results.

A new genetic screen may be able to predict low bone-mineral density, osteoporosis and fracture risk prior to clinical symptoms, according to a retrospective study of nearly 400,000 people by a Stanford researcher.